About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Management and Oxeon Unlock the Power of Women in the Boardroom

New York, New York – February 2, 2016 – Deerfield Management and Oxeon Holdings have joined forces to expand their leadership roles in supporting innovative programs and practices to foster improved diversity in the workplace. On February 2, over 30 female senior healthcare executives with interest in corporate governance will receive training and guidance designed to help them obtain their first boardroom role.

A growing body of academic literature suggests that gender-based heterogeneity in the boardroom is associated with improved ROE and ROI metrics, more effective risk mitigation strategies, enhanced decision making processes, and more diverse management teams, which are in turn associated with lower employee turnover and improved financial performance. Despite these increasingly well characterized benefits, less than 20% of Fortune 1000 board seats are held by women.

“There is a clear disparity between the number of qualified women willing and able to fill corporate board positions and the number of positions actually held by women. As such, we are excited to work with Oxeon to cultivate a new generation of female directors. Not only will the women excel at these positions, but the companies and organizations they serve will benefit from the perspectives, thought processes and problem solving approaches brought by female leaders”, stated Leslie Henshaw, Partner at Deerfield Management.

“Creating a program to educate women on the intricacies of boardroom dynamics is an important initiative we are excited to partner with Deerfield on. Oxeon’s leading position as a healthcare growth services firm creates an opportunity for us to help change the current face of American boardrooms” said Mia Jung, Senior Principal from Oxeon.

The program will consist of four educational sessions including content designed to support both finding and fulfilling board roles. The speaker line-up is made up of an impressive array of female role models, including Sally Susman, EVP of Corporate Affairs at Pfizer, Esther Dyson, Founder and Chairwoman at HICCup, Catherine Bromilow, Partner for PwC’s Center for Board Governance, and Annie Lamont, Partner at Oak HC/FT. Additionally, participants will be paired with a group of experienced mentors who have generously agreed to lend their time and perspective. Over time, Deerfield and Oxeon hope that many of the participants can become candidates for board opportunities emerging from their respective portfolio companies, allowing for practical application of lessons derived from the Women in the Boardroom series.

About Oxeon

Oxeon Holdings is a healthcare growth services firm and is the parent company of Oxeon Partners, an invested executive search firm, Oxeon Investments Funds I & II, and Cien Ventures, an internal venture studio. Oxeon seeks to connect its healthcare company partners with the fundamental drivers of business growth—great people, transformational business partnerships, strategic investments, and next generation business ideas, as well as various advisory and other growth-related services.

For more information visit

About Deerfield

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy.

For more information, please visit


Deerfield Management Company
Karen Heidelberger, 212-692-7140
[email protected]

Oxeon Holdings
Mia Jung
[email protected]